Showing posts with label H1N1. Show all posts
Showing posts with label H1N1. Show all posts
Wednesday, November 18, 2009
B'ham's BioCryst tells of $57MM raise
Birmingham-based BioCryst, which has a product targeted H1N1, said yesterday it intends to raise about $57MM through a stock offering. The release is here and a Birmingham Bus. Journal story here.
Labels:
BioCryst,
biotechnology,
H1N1,
pharmaceuticals,
vaccines
Tuesday, October 13, 2009
Diatherix H1N1 test greenlighted
DIATHERIX Laboratories, based in Huntsville, with offices in Middle Tennessee, announced it has been granted emergency use authorization by the FDA for its DIATHERIX H1N1-09 Influenza Test.
Friday, September 04, 2009
Diatherix driven by H1N1
Diatherix Laboratories is expanding office and lab facilities in Brentwood and in Huntsville, as business picks up for its tests to confirm H1N1 flu and other infectious diseases. Nashville Business Journal reports the story in today's edition (sub.). Diatherix is led by CEO Dennis Grimaud (left), a former president of Tennessee Biotechnology Association and previously a frequent critic of what he described as the inhospitable climate in Tennessee for life sciences ventures.
Subscribe to:
Posts (Atom)